These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 16980074)
21. Use of rituximab in focal glomerulosclerosis relapses after renal transplantation. Dello Strologo L; Guzzo I; Laurenzi C; Vivarelli M; Parodi A; Barbano G; Camilla R; Scozzola F; Amore A; Ginevri F; Murer L Transplantation; 2009 Aug; 88(3):417-20. PubMed ID: 19667947 [TBL] [Abstract][Full Text] [Related]
22. Efficacy of low-dose rituximab for mixed cryoglobulinemia. Visentini M; Granata M; Veneziano ML; Borghese F; Carlesimo M; Pimpinelli F; Fiorilli M; Casato M Clin Immunol; 2007 Oct; 125(1):30-3. PubMed ID: 17692572 [TBL] [Abstract][Full Text] [Related]
23. Rituximab as rescue therapy in anti-neutrophil cytoplasmic antibody-associated vasculitis: a single-centre experience with 15 patients. Lovric S; Erdbruegger U; Kümpers P; Woywodt A; Koenecke C; Wedemeyer H; Haller H; Haubitz M Nephrol Dial Transplant; 2009 Jan; 24(1):179-85. PubMed ID: 18685144 [TBL] [Abstract][Full Text] [Related]
24. Rituximab for the treatment of glomerulonephritis in hepatitis C associated cryoglobulinaemia. Korte MR; van Heerde MJ; de Man RA; Betjes MH Neth J Med; 2008 Jan; 66(1):27-30. PubMed ID: 18219065 [TBL] [Abstract][Full Text] [Related]
25. Rituximab for post-transplant recurrences of FSGS. Bayrakci US; Baskin E; Sakalli H; Karakayali H; Haberal M Pediatr Transplant; 2009 Mar; 13(2):240-3. PubMed ID: 18822107 [TBL] [Abstract][Full Text] [Related]
27. Rituximab treatment for a patient with type I cryoglobulinemic glomerulonephritis. Pandrangi S; Singh A; Wheeler DE; Rossi NF Nat Clin Pract Nephrol; 2008 Jul; 4(7):393-7. PubMed ID: 18493239 [TBL] [Abstract][Full Text] [Related]
28. Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus. Albert D; Dunham J; Khan S; Stansberry J; Kolasinski S; Tsai D; Pullman-Mooar S; Barnack F; Striebich C; Looney RJ; Prak ET; Kimberly R; Zhang Y; Eisenberg R Ann Rheum Dis; 2008 Dec; 67(12):1724-31. PubMed ID: 18250115 [TBL] [Abstract][Full Text] [Related]
29. [Renal involvement of cryoglobulinemia]. Karras A Nephrol Ther; 2018 Apr; 14(2):118-126. PubMed ID: 29545130 [TBL] [Abstract][Full Text] [Related]
30. Rituximab treatment of dysproteinemias affecting the kidney: a review of three cases. Bhat P; Weiss S; Appel GB; Radhakrishnan J Am J Kidney Dis; 2007 Oct; 50(4):641-4. PubMed ID: 17900464 [TBL] [Abstract][Full Text] [Related]
31. Cryoglobulinemia in kidney transplant recipients. Sens YA; Malafronte P; Souza JF; Bruno S; Gonzalez RB; Miorin LA; Jabur P; Forte WC Transplant Proc; 2005 Dec; 37(10):4273-5. PubMed ID: 16387095 [TBL] [Abstract][Full Text] [Related]
32. Initial increase in the cryoglobulin level after rituximab therapy for type II cryoglobulinemia secondary to Waldenström macroglobulinemia does not indicate failure of response. Ghobrial IM; Uslan DZ; Call TG; Witzig TE; Gertz MA Am J Hematol; 2004 Dec; 77(4):329-30. PubMed ID: 15551276 [TBL] [Abstract][Full Text] [Related]
33. Proteinuria after conversion to sirolimus in renal transplant recipients. Sahin GM; Sahin S; Kantarci G; Ergin H Transplant Proc; 2006 Dec; 38(10):3473-5. PubMed ID: 17175308 [TBL] [Abstract][Full Text] [Related]
34. Rituximab for the treatment of type II mixed cryoglobulinemia. Zaja F; De Vita S; Russo D; Michelutti A; Fanin R; Ferraccioli G; Baccarani M Arthritis Rheum; 2002 Aug; 46(8):2252-4; author reply 2254-5. PubMed ID: 12209536 [No Abstract] [Full Text] [Related]
35. Rituximab removes intrarenal B cell clusters in patients with renal vascular allograft rejection. Steinmetz OM; Lange-Hüsken F; Turner JE; Vernauer A; Helmchen U; Stahl RA; Thaiss F; Panzer U Transplantation; 2007 Oct; 84(7):842-50. PubMed ID: 17984836 [TBL] [Abstract][Full Text] [Related]
37. Anti-CD20 monoclonal antibody (rituximab) treatment for hepatitis C-negative therapy-resistant essential mixed cryoglobulinemia with renal and cardiac failure. Ghijsels E; Lerut E; Vanrenterghem Y; Kuypers D Am J Kidney Dis; 2004 May; 43(5):e34-8. PubMed ID: 15112197 [TBL] [Abstract][Full Text] [Related]
38. Successful treatment of chronic antibody-mediated rejection with IVIG and rituximab in pediatric renal transplant recipients. Billing H; Rieger S; Ovens J; Süsal C; Melk A; Waldherr R; Opelz G; Tönshoff B Transplantation; 2008 Nov; 86(9):1214-21. PubMed ID: 19005402 [TBL] [Abstract][Full Text] [Related]
39. [No effect of rituximab in pediatric case of severe nephrotic syndrome and focal segmental glomeruloslerosis accompanied by renal insufficiency]. Hyla-Klekot L; Grenda R; Pulcer B Pol Merkur Lekarski; 2008 Dec; 25(150):519-22. PubMed ID: 19205386 [TBL] [Abstract][Full Text] [Related]
40. Is combination rituximab with cyclophosphamide better than rituximab alone in the treatment of lupus nephritis? Li EK; Tam LS; Zhu TY; Li M; Kwok CL; Li TK; Leung YY; Wong KC; Szeto CC Rheumatology (Oxford); 2009 Aug; 48(8):892-8. PubMed ID: 19478041 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]